The pathological diagnosis of neuroendocrine tumors: common questions and tentative answers
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The pathological diagnosis of neuroendocrine tumors: common questions and tentative answers
Authors
Keywords
-
Journal
VIRCHOWS ARCHIV
Volume 458, Issue 4, Pages 393-402
Publisher
Springer Nature
Online
2011-02-22
DOI
10.1007/s00428-011-1060-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pathology Reporting of Neuroendocrine Tumors: Application of the Delphic Consensus Process to the Development of a Minimum Pathology Data Set
- (2010) David S. Klimstra et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Neuroendocrine gastroenteropancreatic tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2010) K. Oberg et al. ANNALS OF ONCOLOGY
- Molecular markers associated with response to chemotherapy in gastro-entero-pancreatic neuroendocrine tumors
- (2010) Dermot O'Toole et al. ENDOCRINE-RELATED CANCER
- Mammalian target of rapamycin signaling activation patterns in neuroendocrine tumors of the lung
- (2010) Luisella Righi et al. ENDOCRINE-RELATED CANCER
- Reclassification of Neuroendocrine Tumors Improves the Separation of Carcinoids and the Prediction of Survival
- (2010) Birgit Guldhammer Skov et al. Journal of Thoracic Oncology
- The IASLC Lung Cancer Staging Project: Proposals for the Inclusion of Broncho-Pulmonary Carcinoid Tumors in the Forthcoming (Seventh) Edition of the TNM Classification for Lung Cancer
- (2010) William D. Travis et al. Journal of Thoracic Oncology
- Histologic features of low- and intermediate-grade neuroendocrine carcinoma (typical and atypical carcinoid tumors) of the lung
- (2010) Koji Tsuta et al. LUNG CANCER
- Pancreatic endocrine tumors: improved TNM staging and histopathological grading permit a clinically efficient prognostic stratification of patients
- (2010) Aldo Scarpa et al. MODERN PATHOLOGY
- The Pathologic Classification of Neuroendocrine Tumors
- (2010) David S. Klimstra et al. PANCREAS
- Neuroendocrine differentiation in breast cancer: established facts and unresolved problems
- (2010) Luisella Righi et al. SEMINARS IN DIAGNOSTIC PATHOLOGY
- The ENETS and AJCC/UICC TNM classifications of the neuroendocrine tumors of the gastrointestinal tract and the pancreas: a statement
- (2010) Günter Klöppel et al. VIRCHOWS ARCHIV
- Islet 1 (Isl1) Expression is a Reliable Marker for Pancreatic Endocrine Tumors and Their Metastases
- (2009) Anja M. Schmitt et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Immunohistochemical Staining for CDX-2, PDX-1, NESP-55, and TTF-1 Can Help Distinguish Gastrointestinal Carcinoid Tumors From Pancreatic Endocrine and Pulmonary Carcinoid Tumors
- (2009) Amitabh Srivastava et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Somatostatin receptor tissue distribution in lung neuroendocrine tumours: a clinicopathologic and immunohistochemical study of 218 'clinically aggressive' cases
- (2009) L. Righi et al. ANNALS OF ONCOLOGY
- Continuous 5-fluorouracil infusion plus long acting octreotide in advanced well-differentiated neuroendocrine carcinomas. A phase II trial of the Piemonte Oncology Network
- (2009) Maria P Brizzi et al. BMC CANCER
- Prognostic factors influencing survival from metastatic (stage IV) gastroenteropancreatic well-differentiated endocrine carcinoma
- (2009) Cosimo Durante et al. ENDOCRINE-RELATED CANCER
- Pancreatic Endocrine Tumors: Expression Profiling Evidences a Role for AKT-mTOR Pathway
- (2009) Edoardo Missiaglia et al. JOURNAL OF CLINICAL ONCOLOGY
- The German NET-Registry: An Audit on the Diagnosis and Therapy of Neuroendocrine Tumors
- (2009) Ursula Ploeckinger et al. NEUROENDOCRINOLOGY
- Pathologic Classification and Clinical Behavior of the Spectrum of Goblet Cell Carcinoid Tumors of the Appendix
- (2008) Laura H. Tang et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors
- (2008) Ulrich‐Frank Pape et al. CANCER
- Thymidylate Synthase Expression in Gastroenteropancreatic and Pulmonary Neuroendocrine Tumors
- (2008) P. Ceppi et al. CLINICAL CANCER RESEARCH
- Prognostic Factors and Survival in 324 Patients with Pancreatic Endocrine Tumor Treated at a Single Institution
- (2008) S. Ekeblad et al. CLINICAL CANCER RESEARCH
- Predicting Prognosis in Gastroentero-Pancreatic Neuroendocrine Tumors: An Overview and the Value of Ki-67 Immunostaining
- (2008) Mina Jamali et al. ENDOCRINE PATHOLOGY
- Efficacy of RAD001 (Everolimus) and Octreotide LAR in Advanced Low- to Intermediate-Grade Neuroendocrine Tumors: Results of a Phase II Study
- (2008) James C. Yao et al. JOURNAL OF CLINICAL ONCOLOGY
- One Hundred Years After “Carcinoid”: Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United States
- (2008) James C. Yao et al. JOURNAL OF CLINICAL ONCOLOGY
- Priorities for Improving the Management of Gastroenteropancreatic Neuroendocrine Tumors
- (2008) Irvin M. Modlin et al. JNCI-Journal of the National Cancer Institute
- Gastroenteropancreatic neuroendocrine tumours
- (2008) Irvin M Modlin et al. LANCET ONCOLOGY
- Heterogeneity of tumor prognostic markers: a reproducibility study applied to liver metastases of pancreatic endocrine tumors
- (2008) Anne Couvelard et al. MODERN PATHOLOGY
- ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Towards a Standardized Approach to the Diagnosis of Gastroenteropancreatic Neuroendocrine Tumors and Their Prognostic Stratification
- (2008) Günter Klöppel et al. NEUROENDOCRINOLOGY
- Adult diffuse nesidioblastosis: genetically or environmentally induced?
- (2007) Günter Klöppel et al. HUMAN PATHOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started